C4 Therapeutics (CCCC)
US Market

C4 Therapeutics (CCCC) Financial Statements


C4 Therapeutics Financial Overview

C4 Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.75; its P/E ratio is -0.47; C4 Therapeutics is scheduled to report earnings on February 22, 2024, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 2.66M$ 3.76M-$ 6.75M$ 13.83M
Gross Profit$ 2.66M$ 3.76M---
EBIT$ -35.23M$ -34.56M-$ -31.40M$ -26.88M
EBITDA$ -34.77M$ -33.01M-$ -30.99M$ -26.44M
Net Income Common Stockholders$ -35.92M$ -33.11M-$ -31.96M$ -27.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 267.29M$ 49.48M$ 29.75M$ 313.65M$ 307.78M
Total Assets$ 375.01M$ 396.04M$ 116.08M$ 461.44M$ 492.48M
Total Debt$ 83.71M$ 341.01M$ 394.51M$ 88.06M$ 86.32M
Net Debt$ -183.58M$ 291.53M$ 364.76M$ -225.60M$ -221.46M
Total Liabilities$ 141.30M$ 133.57M$ 738.19M$ 143.26M$ 147.88M
Stockholders Equity$ 233.70M$ 262.47M$ 289.22M$ 318.18M$ 344.59M
Cash Flow-
Free Cash Flow$ 458.00K$ -33.78M$ -30.10M$ -31.32M$ -22.72M
Operating Cash Flow$ 458.00K$ -33.19M-$ -28.02M$ -22.20M
Investing Cash Flow-$ 53.53M-$ 19.91M$ 33.23M
Financing Cash Flow-$ -684.00K-$ 361.00K$ 259.00K
Currency in USD

C4 Therapeutics Earnings and Revenue History

C4 Therapeutics Debt to Assets

C4 Therapeutics Cash Flow

C4 Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis